Human medicines European public assessment report (EPAR): Buprenorphine Neuraxpharm, buprenorphine, Date of authorisation: 19/12/2024, Revision: 1, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 16 May 2025 - 14:55

Human medicines European public assessment report (EPAR): Buprenorphine Neuraxpharm, buprenorphine, Date of authorisation: 19/12/2024, Revision: 1, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/buprenorphine-neuraxpharm

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters